Recommendations for Accurate Target Expression Evaluation by Quantitative Flow Cytometry
Cytometry Part A · 2025-07 · 107 (7) · 423-437
DOI: 10.1002/cyto.a.24943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 16.06.2025. Verfasst von Tamara Lekishvili und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Partners AG, Zürich, Switzerland. Hauptthemen laut MEDLINE: Flow Cytometry, Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Molecular Partners AG, Schlieren-Zürich, Switzerland.
Abstract (Originalsprache)
Among various cellular characteristics, flow cytometry can evaluate antigen expression through qualitative or quantitative approaches. For relative quantification, fluorescence intensity (FI) values are converted into quantitative measurements using appropriate reference materials. To quantitatively estimate antigen density or define ligand‐binding sites per cell, antibody binding capacity (ABC) values serve as the preferred metric. Standardizing assays through the conversion of arbitrary FI units into quantitative data is essential for consistency. However, reported ABC values for well‐characterized antigens vary across the literature. This study addresses the challenges in achieving robust and reproducible quantitative flow cytometry data, offering methodological recommendations for accurately assessing target expression. Our research includes a comprehensive investigation of multiple factors, such as conventional and full‐spectrum instruments, antibodies, reagents, matrices, cell density/confluency, cellular autofluorescence, and quantitative kits, to identify the primary sources of variation in ABC calculations. By implementing a systematic and integrated approach, we aim to ensure the generation of reliable and reproducible ABC values. Longitudinal studies provide strong evidence of assay robustness, while the established protocol further supports biomarker evaluation across different matrices and various stages of drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Partners AG, Zürich, Switzerland.
- BioCytex, Marseille, France.
ORCID-Profile: Tamara Lekishvili, Maxime Moulard, Sarah Jetzer, Teresa Maria Frasconi, Anne Goubier, Amelie Croset
Förderung
- Molecular Partners AG, Schlieren-Zürich, Switzerland
Zitieren
APA
Lekishvili, T., Moulard, M., Jetzer, S., Kirkin, A., Frasconi, T. M., Celik, G., Goubier, A., & Croset, A. (2025). Recommendations for Accurate Target Expression Evaluation by Quantitative Flow Cytometry. Cytometry Part A, 107(7), 423-437. https://doi.org/10.1002/cyto.a.24943
Vancouver
Lekishvili T, Moulard M, Jetzer S, Kirkin A, Frasconi TM, Celik G, et al. Recommendations for Accurate Target Expression Evaluation by Quantitative Flow Cytometry. Cytometry Part A. 2025;107(7):423-437. doi:10.1002/cyto.a.24943
BibTeX
@article{Lekishvili2025,
author = {Lekishvili, Tamara and Moulard, Maxime and Jetzer, Sarah and Kirkin, Alisa and Frasconi, Teresa Maria and Celik, Gülsah and Goubier, Anne and Croset, Amelie},
title = {Recommendations for Accurate Target Expression Evaluation by Quantitative Flow Cytometry},
journal = {Cytometry Part A},
year = {2025},
volume = {107},
number = {7},
pages = {423--437},
doi = {10.1002/cyto.a.24943}
}
EUVIMED